American Economic Liberties Project: Court Invalidates Teva's Improper Patents That Keep Inhaler Prices High, Embracing FTC Amicus Brief
June 11, 2024
June 11, 2024
WASHINGTON, June 11 -- The American Economic Liberties Project issued the following statement on June 10, 2024:
* * *
Following a decision from the United States District Court for the District of New Jersey ordering Teva Pharmaceuticals to correct or delete five improperly listed Orange Book patents for its ProAir Inhalers, the American Economic Liberties Project released the following statement.
"This is a major victory for patients facing artificial . . .
* * *
Following a decision from the United States District Court for the District of New Jersey ordering Teva Pharmaceuticals to correct or delete five improperly listed Orange Book patents for its ProAir Inhalers, the American Economic Liberties Project released the following statement.
"This is a major victory for patients facing artificial . . .